BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26

• Genetown

  Aldeyra Therapeutics To Present At The Therapeutic Area Partnerships Meeting

  November 13, 2014

   · 

  2 min read
• Drug Development

  GenKyoTex S.A. Completes Enrollment Into Phase 2 Trial Of NOX1&4 Inhibitor GKT137831 In Diabetic Nephropathy

  November 13, 2014

   · 

  3 min read
• Drug Development

  Clovis Oncology Announces First Patient Enrolled In TIGER-1 Study

  November 13, 2014

   · 

  8 min read
• Business

  The Dow Chemical Company Provides Update Regarding Strategic Investments In Its Plastics Franchise In The Americas

  November 13, 2014

   · 

  1 min read
• Drug Development

  La Jolla Pharmaceutical Company Release: Results From Phase 2 Study Of GCS-100 In Chronic Kidney Disease Being Presented At American Society of Nephrology Kidney Week

  November 13, 2014

   · 

  7 min read
• BioMidwest

  First Patients Enrolled In W. L. Gore & Associates, Inc. Thoracoabdominal Aortic Aneurysm Clinical Study

  November 13, 2014

   · 

  1 min read
• Drug Development

  VBL Therapeutics To Present Interim Phase 2 Data From VB-111 In Recurrent Glioblastoma At 19th Annual Scientific Meeting Of The Society For Neuro-Oncology (SNO)

  November 13, 2014

   · 

  6 min read
• Horizon Pharma plc. Announces Clinical Data On RAYOS® (Prednisone) Delayed-Release Tablets And VIMOVO(R) (Naproxen/Esomeprazole Magnesium) To Be Presented At American College of Rheumatology Annual Meeting

  November 13, 2014

   · 

  10 min read
• Drug Development

  Vascular Pharmaceuticals Initiates Phase 2 Clinical Trial Of VPI-2690B For Diabetic Nephropathy

  November 13, 2014

   · 

  2 min read
• Drug Development

  AM-Pharma Holding BV Presents Preclinical Data On Mode-Of-Action For recAP In Acute Kidney Injury At American Society of Nephrology Meeting

  November 13, 2014

   · 

  4 min read